CVE:CZO Ceapro (CZO) Stock Price, News & Analysis C$0.22 -0.03 (-11.76%) As of 05/31/2024 Add Compare Share Share Stock Analysis Stock AnalysisEarningsBuy This Stock About Ceapro Stock (CVE:CZO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Ceapro alerts:Sign Up Key Stats Today's RangeC$0.23▼C$0.2450-Day RangeC$0.23▼C$0.2352-Week RangeC$0.15▼C$0.54Volume5,850 shsAverage Volume50,562 shsMarket CapitalizationC$688,880.00P/E RatioN/ADividend Yield1.80%Price TargetN/AConsensus RatingN/A Company OverviewCeapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.Read More… Receive CZO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter. Email Address CZO Stock News HeadlinesUniversal Music Restructuring Continues, East Coast Labels Unite via Republic Corps DivisionMarch 12, 2024 | nz.finance.yahoo.comA Complete Breakdown of Kate Middleton's Photoshop ControversyMarch 12, 2024 | nz.finance.yahoo.com[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.April 24, 2025 | Colonial Metals (Ad)Canadian Investment Regulatory Organization Trade Resumption - CZODecember 14, 2023 | finance.yahoo.comAeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical CompanyDecember 14, 2023 | finance.yahoo.comCeapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational HighlightsNovember 29, 2023 | finance.yahoo.comPSA: Charlotte Tilbury's Mystery Box is back, and there's a huge surprise in storeNovember 27, 2023 | nz.finance.yahoo.comCeapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based DiseasesNovember 27, 2023 | finance.yahoo.comSee More Headlines CZO Stock Analysis - Frequently Asked Questions How have CZO shares performed this year? Ceapro's stock was trading at C$0.23 at the beginning of the year. Since then, CZO stock has increased by 0.0% and is now trading at C$0.23. View the best growth stocks for 2025 here. How do I buy shares of Ceapro? Shares of CZO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Ceapro own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ceapro investors own include Franco-Nevada (FNV), Facedrive (FDVRF), FLYHT Aerospace Solutions (FLY), Ackroo (AKR), Badger Daylighting (BAD), BeWhere (BEW) and BlueRush (BTV). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:CZO CIKN/A Webwww.ceapro.com Phone+1-780-4214555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.08) Trailing P/E RatioN/A Forward P/E Ratio5.63 P/E GrowthN/ANet IncomeC$-243,041.50 Net Margins-69.73% Pretax MarginN/A Return on Equity-21.67% Return on Assets-11.30% Debt Debt-to-Equity Ratio8.28 Current Ratio7.10 Quick Ratio18.88 Sales & Book Value Annual SalesC$348,522.40 Price / Sales1.98 Cash FlowC$0.06 per share Price / Cash Flow3.94 Book ValueC$0.33 per share Price / Book0.68Miscellaneous Outstanding Shares3,061,689Free FloatN/AMarket CapC$688,880.00 OptionableNot Optionable Beta1.38 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (CVE:CZO) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ceapro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ceapro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.